Pfizer to Deliver 200 Million COVID-19 Vaccines to US Earlier Than Expected
On Tuesday, Pfizer announced that it plans to deliver 200 million COVID-19 vaccines to the US by May, according to CNBC.
Pfizer had previously forecasted that the 200 million doses would be delivered by July. The information was disclosed by slides published ahead of Pfizer's fourth-quarter earnings report.
The slide deck also revealed that the company expects to deliver 2 billion doses globally by the end of 2021. As of January 31, Pfizer had delivered around 29 million doses of its vaccine. As of Monday, 17 million Pfizer vaccines have been administered, according to the Centers for Disease Control and Prevention.
Pfizer has struggled to meet the demand for shots. Recently, it partnered with French drugmaker Sanofi to help produce 100 million doses of the vaccine. Pfizer also reported that it expects to bring in around $15 billion in revenue from coronavirus vaccines this year.
Lastly, the company stated it is "prepared to respond" if a mutated strain of the novel coronavirus proves its vaccine ineffective. Individuals will “likely need to boost regularly to maintain immune response and to counter emerging variant strains.”
This is great news for US citizens who have struggled emotionally, financially, and physically throughout the pandemic. The sooner vaccines can be administered to every willing citizen, the better.